Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-ye Wang

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
BMC Cancer|September 3, 2010
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinomaWan-li Liu, Xian-zhi Guo, Lan-jun Zhang, et al.
Journal of Cellular Biochemistry|October 17, 2018
Differential expression profiles of long noncoding RNAs in synchronous multiple and solitary primary esophageal squamous cell carcinomas: A microarray analysisQi-Wen Li, Li Ma, Bo Qiu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2003
[Giant pathologic section in the study of optimal length of surgical resection for esophageal carcinoma]Guo-wei Ma, Tie-hua Rong, Qiu-liang Wu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|January 13, 2006
[Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma]Xu Zhang, Tie-Hua Rong, Yu Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|February 13, 2004
[Shrinkage of resected specimens of esophageal carcinoma]Guo-Wei Ma, Tie-Hua Rong, Hao Long, et al.
Cancer Letters|November 7, 2017
Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1Xiao-Ping Huang, Xuan Li, Min-Yi Situ, et al.
The Lancet. Oncology|January 9, 2025
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trialDan-Yun Ruan, Fu-Rong Liu, Xiao-Li Wei, et al.
Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMC Cancer|September 3, 2010
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinomaWan-li Liu, Xian-zhi Guo, Lan-jun Zhang, et al.
Journal of Cellular Biochemistry|October 17, 2018
Differential expression profiles of long noncoding RNAs in synchronous multiple and solitary primary esophageal squamous cell carcinomas: A microarray analysisQi-Wen Li, Li Ma, Bo Qiu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2003
[Giant pathologic section in the study of optimal length of surgical resection for esophageal carcinoma]Guo-wei Ma, Tie-hua Rong, Qiu-liang Wu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|January 13, 2006
[Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma]Xu Zhang, Tie-Hua Rong, Yu Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|February 13, 2004
[Shrinkage of resected specimens of esophageal carcinoma]Guo-Wei Ma, Tie-Hua Rong, Hao Long, et al.
Cancer Letters|November 7, 2017
Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1Xiao-Ping Huang, Xuan Li, Min-Yi Situ, et al.
The Lancet. Oncology|January 9, 2025
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trialDan-Yun Ruan, Fu-Rong Liu, Xiao-Li Wei, et al.
Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
Pageof 5